The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / DNA Methylation Modifies Genetic Risk for Rheumatoid Arthritis

DNA Methylation Modifies Genetic Risk for Rheumatoid Arthritis

April 12, 2013 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

A first-of-its-kind study has been published that integrates genotype and epigenotype data across the entire genome. The work was performed in patients with rheumatoid arthritis (RA) and controls. The study provides the first evidence that DNA methylation mediates a disease genotype. In other words, it is the DNA methylation that allows the genotype to be expressed as RA.

You Might Also Like
  • Genetic Risk Factors for Rheumatoid Arthritis Merit More Research
  • Distinct DNA Methylation Patterns Associated with Myalgic Encephalomyelitis
  • B-Cell Genes Interact to Increase Risk for Rheumatoid Arthritis
Also By This Author
  • Varicella Zoster Virus May Cause Giant Cell Arteritis

The researchers accomplished this feat through analyzing cell-type distributions. They created a new approach to the study of epigenetics that allows for the correction of cell heterogeneity and the filtering out of signals that may be caused by the disease itself. These adjustments allow investigators to distinguish between DNA methylation changes that are truly a marker of causal mechanism and those that are a consequence of disease.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The success of the approach paves the way for similar human epigenetic studies in the future. Yun Liu, PhD, of Johns Hopkins University School of Medicine in Baltimore, and colleagues published their results in Nature Biotechnology.1 They explain in their publication that the approach can be applied to many tissue sources as long as cell-specific methylation signatures are available for the particular cell mixture. The authors acknowledge, however, that the new approach may still include residual confounding between cell types.

In analyzing patients with RA, the authors identified ten CpG sites that represent signals across five genomic regions. They also identified evidence for single-nucleotide polymorphism (SNP) regulation of DNA methylation variation. They propose that one of the genes in these regions should show altered regulation related to DNA methylation and that this novel nonlinear gene–protein relationship will be found to contribute to RA.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Tomas J. Ekstrom, PhD, of the Karolinska Institute in Stockholm, Sweden, was one of the authors of the study. He explained its clinical implications to The Rheumatologist via email: “If we pin down genetic and environmental factors involved in the pathogenic initiation process, clinicians might be able to employ new biomarkers and external influences to find vulnerability to RA. In addition, since we found that DNA methylation may mediate genetic vulnerability and that epigenetic modifications are potentially reversible, maybe the future will hand us therapeutic tools to reverse a pathogenic process, or prevent it from starting.”

The current study was performed using blood samples from patients. Dr. Ekstrom explained that the use of blood cells is convenient and relevant, but that future studies could investigate cells from target tissues such as the synovium. An analysis of these cells might shed light on the mechanisms involved in the actual joint degradation process.

Pages: 1 2 | Single Page

Filed Under: Conditions, Research Reviews, Rheumatoid Arthritis Tagged With: DNA, epigenetics, genetic, RA, Rheumatoid arthritis

You Might Also Like:
  • Genetic Risk Factors for Rheumatoid Arthritis Merit More Research
  • Distinct DNA Methylation Patterns Associated with Myalgic Encephalomyelitis
  • B-Cell Genes Interact to Increase Risk for Rheumatoid Arthritis
  • Is Chemical Exposure Linked to DNA Methylation Dysregulation in SLE Patients?

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)